Auto-injectors are mostly spring-loaded syringes used for injecting oneself with a preloaded, single dose of a drug. These injectors are easy to use and are generally utilized in the case of multiple sclerosis, anaphylaxis, or rheumatoid arthritis. The growing prevalence of anaphylaxis and allergies from food have fueled the demand for auto-injectors globally. Apart from this, the implementation of favorable reimbursement policies by various governments across the world is also propelling this market significantly.
Download Report Brochure For Industry Insight: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4199
The research report presents an in-depth analysis of the global market for auto-injectors. It studies the market on four fronts: The type of product, manufacturing design, application, and the region. Based on the type of product, the market has been categorized into fillable (reusable) auto-injectors and prefilled (disposable) auto-injectors. The prefilled auto-injectors segment enjoys a higher demand than the fillable auto-injectors segment on account of the ease of usage provided by prefilled auto-injectors.
By manufacturing design, the market has been classified into standardized auto-injectors and customized auto-injectors. The standardized auto-injectors segment dominated the overall market in 2013. However, analysts anticipate the customized auto-injectors segment to record the fastest growth during the forecast period, states the report.
Application-wise, the market has been grouped into rheumatoid arthritis, multiple sclerosis, anaphylaxis, and other applications. In 2013, the demand for auto-injectors was the highest from the anaphylaxis segment.
Regionally, the research report has segmented the worldwide market for auto-injectors into North America, Asia Pacific, Europe, and the Rest of the World. North America led the global market in 2013 with a share of 70%. The increased prevalence of anaphylaxis and the rise in the disposable income of individuals, enabling them to afford expensive treatments, have fueled the demand for auto-injectors in this region significantly. The presence of a favorable reimbursement environment has also boosted this regional market in the recent past.
Asia Pacific, however, is projected to emerge as the most promising regional market for auto-injectors over the forecast period. The rising incidence of multiple sclerosis and anaphylaxis in Australia and New Zealand, together with favorable reimbursement options in New Zealand, is likely to propel this regional market considerably during the forecast period. The growing awareness regarding novel treatment methods and increasing disposable income of people are also expected to drive the Asia Pacific auto-injectors market in the coming years, notes the research study.
Browse Full Report With TOC: http://www.transparencymarketresearch.com/global-auto-injectors-market.html
Ypsomed Holding AG, Unilife Corp., Scandinavian Health Ltd., Sanofi, Novartis International AG, Mylan Inc., Biogen Idec, Becton, Dickinson & Co., and Antares Pharma Inc. are the major international players in the global auto-injectors market profiled in this market report.